MoCRA Compliance Checklist for US Brands Manufacturing in Korea
You’ve done the hard part. You found a Korean manufacturer, you have your formulas, and you’re ready to build the K-beauty brand you’ve been planning for months.
Then someone mentions MoCRA compliance — and suddenly you’re looking at a wall of FDA regulatory language trying to figure out what any of it actually means for you, as a US brand owner sourcing from Korea.
Here’s the uncomfortable truth that nobody in the sourcing space is talking about: Amazon removed thousands of cosmetic listings in 2024 for MoCRA non-compliance, and US Customs and Border Protection is actively detaining Korean cosmetic shipments at the border. This isn’t a future problem. It’s a right-now problem.
But it’s also a manageable one — if you know what to check before your products leave Korea. This is that checklist.
What MoCRA Actually Requires (The Quick Version)
Before MoCRA, the US cosmetics industry was operating under regulations that hadn’t been meaningfully updated since 1938. No, really — 1938. Brands could sell cosmetics with almost zero required interaction with the FDA. That era is over.
MoCRA — the Modernization of Cosmetics Regulation Act of 2022 — established five core requirements that now apply to anyone selling cosmetics in the US market. As a US brand owner sourcing from Korea, every single one of these touches you directly. Some of them touch your Korean manufacturer too. That’s why the compliance process needs to start before production — not after your shipment clears customs.
Your Korean Manufacturer Must Be FDA-Registered
Korean labeling regulations are different from US FDA requirements. A label that’s perfectly compliant in Korea can get your shipment detained at a US port. Your Korean manufacturer is not responsible for ensuring your label meets US requirements. That’s on you.
Your US label needs: a product identity statement (what it is), net quantity on the principal display panel, your name and US address as distributor or brand, a full ingredient list in descending order of predominance using INCI names, and any required warnings. All of it in English. If you keep Korean text on your packaging, all required information must also appear in English.
Get your final label artwork reviewed by someone who knows FDA cosmetic labeling requirements before you go to print. A label review costs a fraction of what it costs to reprint packaging or have a shipment refused at the border.
Watch Your Claims — This Is What’s Killing Amazon Listings
A cosmetic claim is about how your product affects appearance: “visibly reduces the look of fine lines,” “leaves skin looking more radiant,” “improves the appearance of skin tone.” These are fine. A drug claim is about how your product affects the structure or function of the body: “reduces wrinkles,” “stimulates collagen production,” “treats acne,” “repairs skin cells.” The FDA considers these claims to mean the product is a drug — which requires FDA approval before it can be sold.
Amazon’s compliance systems scan listings for language that triggers drug claim flags. If your title says “anti-aging treatment” or your bullets say “repairs skin barrier,” your listing can be deactivated. This is what happened en masse in 2024 — and it caught plenty of legitimate brands that were simply sloppy with their copywriting. Review every piece of copy: your label, your Amazon listing, your website, your social media. K-beauty marketing language tends to be more efficacy-forward than what US regulations allow.
Adverse Event Reporting and Safety Substantiation
If a customer has a serious adverse reaction to your product — hospitalization, significant disfigurement, serious infection, or anything requiring medical intervention — you must report it to the FDA within 15 business days. You also need to retain records of all adverse events for at least six years. Most indie brands aren’t thinking about this on launch day. You need a process in place before your first sale: a designated contact for product complaints, a log to document reports, and clarity on what “serious” means under MoCRA’s definition.
On safety substantiation: MoCRA requires you to maintain records supporting the adequate safety of your products. The FDA won’t test your product before you sell it — but they can ask for your records. Request all safety documentation from your Korean manufacturer before finalizing production: stability testing, microbial testing, challenge testing. Reputable Korean ODMs have this. Make sure you get it and keep it organized.
